In tumor-bearing individuals, through interactions between the microbiome and TLR5+ cells that occur at places of bacterial colonization, TLR5 competence drives systemic IL-6 up-regulation, while deficiencies in TLR5 signaling are associated with higher circulating levels of IL-17. Here, TLR5 is linked to neoplasm.